Page last updated: 2024-08-16

mitomycin and everolimus

mitomycin has been researched along with everolimus in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Al-Batran, SE; Atmaca, A; Jäger, E; Pauligk, C; Pustowka, A; Werner, D	1

Reviews

1 review(s) available for mitomycin and everolimus

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for mitomycin and everolimus

Article	Year
Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma. Cancer medicine, 2013, Volume: 2, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Esophageal Neoplasms; Everolimus; Female; Humans; Male; Middle Aged; Mitomycin; Sirolimus; Stomach Neoplasms; Survival Analysis	2013

Article

Year

Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma.

Cancer medicine, 2013, Volume: 2, Issue:3

Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Esophageal Neoplasms; Everolimus; Female; Humans; Male; Middle Aged; Mitomycin; Sirolimus; Stomach Neoplasms; Survival Analysis

2013